Mathes Company, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History

Mathes Company, Inc.

$279 Million
Q3 2025

A detailed history of Mathes Company, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Mathes Company, Inc. holds 3,470 shares of XBI stock, worth $395,614. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,470

Previous 4,770 27.25%

Holding current value

$395,614

Previous $396,000 12.12%

% of portfolio

0.12%

Previous 0.15%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$83.08 - $100.2 $108,004 - $130,260	-1,300 Reduced 27.25%	3,470 $348,000
Q2 2025 Aug 05, 2025	SELL	$69.8 - $85.28 $123,895 - $151,372	-1,775 Reduced 27.12%	4,770 $396,000
Q1 2025 May 01, 2025	SELL	$81.1 - $94.7 $89,210 - $104,170	-1,100 Reduced 14.39%	6,545 $531,000
Q4 2024 Jan 31, 2025	SELL	$89.81 - $104.0 $132,020 - $152,880	-1,470 Reduced 16.13%	7,645 $689,000
Q3 2024 Oct 29, 2024	SELL	$90.87 - $102.43 $29,532 - $33,289	-325 Reduced 3.44%	9,115 $901,000

Q2 2024 Aug 12, 2024	SELL	$82.22 - $94.12 $104,830 - $120,003	-1,275 Reduced 11.9%	9,440 $875,000
Q1 2024 May 02, 2024	BUY	$87.05 - $102.89 $439,602 - $519,594	5,050 Added 89.14%	10,715 $1.02 Million
Q4 2022 Jan 25, 2023	SELL	$76.72 - $85.66 $103,572 - $115,641	-1,350 Reduced 19.24%	5,665 $470,000
Q3 2022 Oct 18, 2022	SELL	$75.06 - $94.9 $512,284 - $647,692	-6,825 Reduced 49.31%	7,015 $556,000
Q2 2022 Aug 01, 2022	BUY	$62.81 - $96.09 $158,281 - $242,146	2,520 Added 22.26%	13,840 $1.03 Million
Q1 2022 Jun 15, 2022	BUY	$81.07 - $115.44 $385,082 - $548,340	4,750 Added 72.3%	11,320 $1.02 Million
Q4 2021 Feb 04, 2022	BUY	$108.77 - $134.15 $714,618 - $881,365	6,570 New	6,570 $736,000
Q3 2021 Oct 29, 2021	SELL	$118.69 - $138.49 $770,891 - $899,492	-6,495 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$122.48 - $139.69 $194,130 - $221,408	1,585 Added 32.28%	6,495 $879,000
Q1 2021 Apr 28, 2021	BUY	$129.36 - $173.99 $64,680 - $86,995	500 Added 11.34%	4,910 $666,000
Q4 2020 Jan 20, 2021	SELL	$110.36 - $151.14 $22,623 - $30,983	-205 Reduced 4.44%	4,410 $621,000
Q3 2020 Oct 26, 2020	BUY	$103.87 - $120.36 $479,360 - $555,461	4,615 New	4,615 $514,000

Others Institutions Holding XBI

# of Institutions

837

Shares Held

121M

Call Options Held

28.4M

Put Options Held

34.2M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mathes Company, Inc. with notifications on news.

Account

Mathes Company, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History